Valeo Pharma Inc
TSX:VPH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Valeo Pharma Inc
Valeo Pharma Inc
Other Current Liabilities
Valeo Pharma Inc
Other Current Liabilities Peer Comparison
TH
EDT
CPH
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Valeo Pharma Inc
TSX:VPH
|
Other Current Liabilities
CA$4.2m
|
CAGR 3-Years
244%
|
CAGR 5-Years
141%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Other Current Liabilities
$7.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
35%
|
CAGR 10-Years
20%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Other Current Liabilities
CA$8.4m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Other Current Liabilities
CA$7.7m
|
CAGR 3-Years
126%
|
CAGR 5-Years
99%
|
CAGR 10-Years
9%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Other Current Liabilities
$494k
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-13%
|
|
V
|
Vext Science Inc
CNSX:VEXT
|
Other Current Liabilities
$4.2m
|
CAGR 3-Years
196%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
See Also
What is Valeo Pharma Inc's Other Current Liabilities?
Other Current Liabilities
4.2m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Other Current Liabilities amounts to 4.2m CAD.
What is Valeo Pharma Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
141%
Over the last year, the Other Current Liabilities growth was 101%. The average annual Other Current Liabilities growth rates for Valeo Pharma Inc have been 244% over the past three years , 141% over the past five years .
You don't have any saved screeners yet
